CSL (CSLLY) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free CSLLY Stock Alerts $94.97 +2.09 (+2.25%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 10:25 AM | investorplace.comCSLR Stock Earnings: Complete Solaria Misses EPS, Misses Revenue for Q1 2024May 2, 2024 | markets.businessinsider.comCSL : Real-World Evidence Study Proves Effectiveness Of Cell-Based Quadrivalent Influenza VaccinesMay 2, 2024 | prnewswire.comRecently Published Real-World Evidence Study Shows Effectiveness of Cell-Based Quadrivalent Influenza Vaccine Over Three SeasonsApril 28, 2024 | msn.comHere is the dividend forecast to 2028 for CSL sharesApril 25, 2024 | investorplace.comCSL Stock Earnings: Carlisle Companies Beats EPS, Beats Revenue for Q1 2024April 24, 2024 | prnewswire.comCSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA NephropathyApril 16, 2024 | msn.comHow much do you need to invest in CSL shares for $8,000 in annual dividends?April 12, 2024 | markets.businessinsider.comUBS Sticks to Their Buy Rating for CSL (CMXHF)April 9, 2024 | afr.comMacquarie brokers say CSL is heading to $500 per shareApril 5, 2024 | investorplace.comCSLR Stock Earnings: Complete Solaria Beats EPS, Misses Revenue for Q4 2023April 3, 2024 | marketbeat.comAkebia Therapeutics Surges on FDA Approval for Anemia Treatment (CSLLY)Akebia Therapeutics Inc. (NASDAQ: AKBA) is a biopharmaceutical company specializing in developing treatments for chronic kidney diseases (CKD) and anemiaApril 2, 2024 | fool.com.auOwn CSL shares? You're receiving a healthy dividend boost today!March 28, 2024 | finance.yahoo.comVafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patientsMarch 26, 2024 | afr.comBlood giant CSL works up $US1 billion-plus bond deal; banks mandatedMarch 11, 2024 | finance.yahoo.comCSL Ltd's Dividend AnalysisMarch 6, 2024 | prnewswire.comCSL Seqirus is Fully Prepared to Implement the FDA's Vaccines and Related Biological Products Advisory Committee Trivalent Influenza Vaccines Strain Selection for the 2024/25 U.S. SeasonFebruary 15, 2024 | markets.businessinsider.comWilsons downgrades CSL (CMXHF) to a HoldFebruary 13, 2024 | fool.com.auCSL shares tumble despite first-half earnings beatFebruary 13, 2024 | afr.comWhat we learnt from CSL, Challenger, Seek and Breville’s resultsFebruary 13, 2024 | finanznachrichten.deCSL Limited: Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³February 12, 2024 | fool.com.auCSL share price on watch amid 20% profit jumpFebruary 12, 2024 | marketwatch.comCSL Says 1H Profit Rises, Boosts Dividend -- UpdateFebruary 12, 2024 | afr.comCSL shrugs off trial setback to post double-digit earnings growthFebruary 12, 2024 | wsj.comCSL Profit Rises, Boosts DividendFebruary 12, 2024 | msn.comCSL Limited falls after Phase 3 setback for key trialFebruary 12, 2024 | msn.comAsian stocks move little in holiday-thinned trade; CSL drags on AustraliaFebruary 6, 2024 | msn.comCSL and Arcturus’ Covid-19 booster found to prolong immunityFebruary 5, 2024 | finance.yahoo.comNew COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine BoosterJanuary 29, 2024 | fool.com.auAre CSL shares set for an earnings boost?January 23, 2024 | fool.com.auIs now the right time to buy CSL shares? Here's my takeJanuary 23, 2024 | theglobeandmail.comAll hands on deck for employee growth at CSLJanuary 14, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Ansell (OtherANSLF) and CSL (OtherCMXHF)January 3, 2024 | finanznachrichten.deCSL Behring Announces Availability of Hizentra (Immune Globulin Subcutaneous [Human] 20% Liquid) 10g Prefilled SyringeJanuary 2, 2024 | markets.businessinsider.comLoop Capital Markets Keeps Their Buy Rating on Carlisle Companies (CSL)December 21, 2023 | msn.comCSL worker held for 'spying' on Navy shipDecember 18, 2023 | ca.finance.yahoo.comQURE Jan 2024 25.000 callDecember 17, 2023 | ca.finance.yahoo.comQURE Jan 2024 5.000 callDecember 17, 2023 | ca.finance.yahoo.comQURE Jan 2024 25.000 putDecember 16, 2023 | ca.finance.yahoo.comQURE Jan 2024 9.000 callDecember 16, 2023 | ca.finance.yahoo.comQURE Jan 2024 9.000 putDecember 14, 2023 | msn.comBMW E46 Owners: Don’t Sleep on Vorsteiner’s Carbon M3 CSL Body KitDecember 14, 2023 | finance.yahoo.comCSL's Garadacimab, a First-in-Class Factor XIIa Inhibitor, Receives FDA and EMA Filing AcceptanceDecember 4, 2023 | afr.comHedge funds divided on CSL as Perpetual and Pendal place opposing betsNovember 28, 2023 | msn.comArcturus, CSL win approval for world’s first self-amplifying mRNA vaccine in JapanNovember 28, 2023 | msn.comThese aftermarket carbon bits can make your E46 BMW M3 look like a CSLNovember 16, 2023 | fool.com.auCan CSL shares reach $300 by Christmas?October 26, 2023 | ca.finance.yahoo.comHealth Canada Authorizes CSL's HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Hemophilia BOctober 26, 2023 | afr.comHow CSL’s new CEO stacks up against Brian McNamee and Paul PerreaultOctober 18, 2023 | fool.com.auWill I look back and regret not buying CSL shares at $237 today?October 16, 2023 | markets.businessinsider.comCSL (CMXHF) Gets a Buy from Macquarie Get CSL News Delivered to You Automatically Sign up to receive the latest news and ratings for CSLLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide CSLLY Media Mentions By Week CSLLY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CSLLY News Sentiment▼0.230.55▲Average Medical News Sentiment CSLLY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CSLLY Articles This Week▼21▲CSLLY Articles Average Week Get CSL News Delivered to You Automatically Sign up to receive the latest news and ratings for CSLLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BMY News Today GSK News Today ZTS News Today REGN News Today VRTX News Today SNY News Today TAK News Today PFE News Today ABT News Today RHHBY News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CSLLY) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldDoes this make you sick?Allegiance GoldTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
